News and Stories About early detection

After Barbara Kenner, PhD, lost her husband just two months after his pancreatic cancer diagnosis, she made it her mission to find a way to detect pancreatic cancer earlier. Barbara has been instrumental in supporting PanCAN’s recently announced Early Detection Initiative and the research that preceded and shaped it.

Passionate advocates and volunteers paved the way for our Early Detection Initiative.

Chief Science Officer Lynn Matrisian shares her priorities, proudest accomplishments.

Brothers’ hunch led them to fund research in their dad’s memory.

Ways to find pancreatic cancer in the earliest stages are urgently needed.

Diabetes can be both a risk factor and an early symptom of pancreatic cancer.

Earlier detection leads to more treatment options and improved survival.

The Atlantic’s People v. Cancer summit takes place Wednesday, Nov. 18, 2020, and PanCAN’s President and CEO Julie Fleshman, JD, […]
READ MORE

Timing is everything. And when Chuck Paulausky of Chandler, Ariz., happened to turn on “Jeopardy!” one evening last November and […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE

The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

The U.S. Preventive Services Task Force (USPSTF) continues to recommend against population-wide screening for pancreatic cancer, as announced today on […]
READ MORE

How does someone trained in spin physics – the study of the “magnetic moment” of elementary particles – apply that […]
READ MORE

Editor’s note: April is National Cancer Control Month, which highlights factors that can help prevent or combat cancer, including early […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

Pancreatic cancer is notoriously difficult to find in its earlier, and more treatable stages. For this reason, research teams across […]
READ MORE

Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE

Editor’s note: Today’s edition of the 2018 Year in Review series continues the topic of research. Yesterday’s article covered treatment […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

Pancreatic cancer is anticipated to become the second leading cause of cancer-related death in the U.S. around 2020. More awareness […]
READ MORE

In a study recently published in the prestigious Journal of Clinical Oncology, researchers investigated the accuracy of a biomarker panel […]
READ MORE

A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE

The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE

In a study published today in the Journal of the National Cancer Institute (JNCI), researchers found that new-onset diabetes in […]
READ MORE

Editor’s note: There is news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June […]
READ MORE

A team of researchers from the University of California, San Diego (UCSD), recently published a study evaluating a new strategy […]
READ MORE

Editor’s note: You may have heard earlier this week on our website and from other media sources that former Senate […]
READ MORE

Editor’s note: You may have seen stories in the news and here on our website about a new blood test […]
READ MORE

Yesterday, a collaborative team of scientists, primarily from Johns Hopkins University, published a paper in the well regarded journal Science, […]
READ MORE

Editor’s note: Welcome to the second part of our 2017 research highlights recap (we’re pretty excited that it’s taking two […]
READ MORE

The National Cancer Institute (NCI) recently funded four new teams of researchers through its Pancreatic Cancer Detection Consortium (PCDC). According […]
READ MORE

Editor’s note: It’s Pancreatic Cancer Awareness Month, and our focus is “Demand Better. For Patients. For Survival.” Each week, we’re […]
READ MORE

Editor’s note: Pancreatic Cancer Awareness Month kicked off a few weeks early this year and continues through November. Our focus […]
READ MORE

While most people are familiar with types 1 and 2 diabetes, there is a third, less common type, known as […]
READ MORE

The pancreatic cancer community is no stranger to loss. With a five-year survival rate of just 9 percent, pancreatic cancer […]
READ MORE

In a forward-looking study of patients diagnosed with various types of cysts of the pancreas, researchers at the University of […]
READ MORE

Back when he was a postdoctoral researcher, grantee Kazuki Sugahara, MD, PhD, found that a peptide, or small piece of […]
READ MORE

You may have seen the news about a new app, called BiliScreen, being developed at the University of Washington that […]
READ MORE

2017 Grant Recipients and Pancreatic Cancer Survivor Featured on KATU-TV in Portland, Ore. Last month, our organization awarded 17 grants […]
READ MORE

Pancreatic Cancer Action Network invests in precision medicine and early detection to change outcomes for the world’s toughest cancer MANHATTAN […]
READ MORE

Finding out that you have a cyst on your pancreas is a terrifying moment of uncertainty. What are the chances […]
READ MORE

There is a complex relationship between diabetes and pancreatic cancer – diabetes can be considered both a symptom and a […]
READ MORE

In April 2016, Jiyoung Ahn, PhD, recipient of the 2012 The Daniel and Janet Mordecai – Career Development Award, presented […]
READ MORE

One of the reasons that pancreatic cancer is particularly challenging to clinicians is that the majority of cases are diagnosed […]
READ MORE